Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
02 03 2021
Historique:
received: 17 11 2020
accepted: 25 02 2021
entrez: 3 3 2021
pubmed: 4 3 2021
medline: 16 3 2021
Statut: ppublish

Résumé

Pediatric COVID-19 following SARS-CoV-2 infection is associated with fewer hospitalizations and often milder disease than in adults. A subset of children, however, present with Multisystem Inflammatory Syndrome in Children (MIS-C) that can lead to vascular complications and shock, but rarely death. The immune features of MIS-C compared to pediatric COVID-19 or adult disease remain poorly understood. We analyzed peripheral blood immune responses in hospitalized SARS-CoV-2 infected pediatric patients (pediatric COVID-19) and patients with MIS-C. MIS-C patients had patterns of T cell-biased lymphopenia and T cell activation similar to severely ill adults, and all patients with MIS-C had SARS-CoV-2 spike-specific antibodies at admission. A distinct feature of MIS-C patients was robust activation of vascular patrolling CX3CR1+ CD8+ T cells that correlated with the use of vasoactive medication. Finally, whereas pediatric COVID-19 patients with acute respiratory distress syndrome (ARDS) had sustained immune activation, MIS-C patients displayed clinical improvement over time, concomitant with decreasing immune activation. Thus, non-MIS-C versus MIS-C SARS-CoV-2 associated illnesses are characterized by divergent immune signatures that are temporally distinct from one another and implicate CD8+ T cells in the clinical presentation and trajectory of MIS-C.

Identifiants

pubmed: 33653907
pii: 6/57/eabf7570
doi: 10.1126/sciimmunol.abf7570
pmc: PMC8128303
mid: NIHMS1697788
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI007324
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : F99 CA234842
Pays : United States
Organisme : NCI NIH HHS
ID : K08 CA230157
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI082630
Pays : United States
Organisme : NCI NIH HHS
ID : K00 CA234842
Pays : United States
Organisme : NICHD NIH HHS
ID : R61 HD105594
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121250
Pays : United States
Organisme : NIH HHS
ID : AI105343
Pays : United States
Organisme : NIH HHS
ID : HL143613
Pays : United States
Organisme : NIAID NIH HHS
ID : K08 AI136660
Pays : United States
Organisme : NIH HHS
ID : AI082630
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL137006
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL137915
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007586
Pays : United States
Organisme : NIH HHS
ID : HL137915
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009140
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA193776
Pays : United States
Organisme : NHLBI NIH HHS
ID : R38 HL143613
Pays : United States
Organisme : NIAID NIH HHS
ID : K08 AI135091
Pays : United States
Organisme : NIH HHS
ID : CA230157
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK112217
Pays : United States
Organisme : NIH HHS
ID : HL137006
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI105343
Pays : United States

Investigateurs

Sharon Adamski (S)
Zahidul Alam (Z)
Mary M Addison (MM)
Katelyn T Byrne (KT)
Aditi Chandra (A)
Hélène C Descamps (HC)
Nicholas Han (N)
Yaroslav Kaminskiy (Y)
Shane C Kammerman (SC)
Justin Kim (J)
Allison R Greenplate (AR)
Jacob T Hamilton (JT)
Nune Markosyan (N)
Julia Han Noll (JH)
Dalia K Omran (DK)
Ajinkya Pattekar (A)
Eric Perkey (E)
Elizabeth M Prager (EM)
Dana Pueschl (D)
Austin Rennels (A)
Jennifer B Shah (JB)
Jake S Shilan (JS)
Nils Wellhausen (N)
Ashley N Vanderbeck (AN)

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright © 2021, American Association for the Advancement of Science.

Références

Immunity. 2016 Dec 20;45(6):1270-1284
pubmed: 27939671
J Clin Invest. 2020 Nov 2;130(11):5942-5950
pubmed: 32701511
Nat Rev Immunol. 2002 Apr;2(4):251-62
pubmed: 12001996
Sci Transl Med. 2019 Nov 27;11(520):
pubmed: 31776286
PLoS Pathog. 2015 Oct 20;11(10):e1005177
pubmed: 26485519
Immunity. 2018 May 15;48(5):1029-1045.e5
pubmed: 29768164
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Front Immunol. 2012 Jan 02;2:82
pubmed: 22566871
J Clin Invest. 2020 Nov 2;130(11):5967-5975
pubmed: 32730233
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
JAMA Pediatr. 2020 Oct 1;174(10):e202430
pubmed: 32492092
J Infect Dis. 2020 May 11;221(11):1762-1769
pubmed: 32227123
Lancet Child Adolesc Health. 2020 Sep;4(9):669-677
pubmed: 32653054
Sci Immunol. 2020 Jul 29;5(49):
pubmed: 32727884
J Immunol. 2015 Sep 15;195(6):2861-9
pubmed: 26276874
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4719-24
pubmed: 25775592
Mol Interv. 2010 Oct;10(5):263-70
pubmed: 21045240
Pediatrics. 2018 Apr;141(4):
pubmed: 29440502
Annu Rev Immunol. 2008;26:677-704
pubmed: 18173375
Sci Transl Med. 2013 Mar 13;5(176):176ra32
pubmed: 23486778
J Infect Dis. 2016 Dec 15;214(12):1808-1816
pubmed: 27703039
Pediatrics. 2020 Oct;146(4):
pubmed: 32680880
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Nat Rev Immunol. 2020 Aug;20(8):453-454
pubmed: 32546853
Nat Immunol. 2021 Jan;22(1):25-31
pubmed: 33154590
J Immunol. 2002 Jun 15;168(12):6173-80
pubmed: 12055230
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):E3216-24
pubmed: 23922396
Annu Rev Immunol. 2011;29:621-63
pubmed: 21314428
Pediatrics. 2020 Dec;146(6):
pubmed: 32879033
Acta Pharmacol Sin. 2013 Oct;34(10):1251-6
pubmed: 23974513
MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):923-929
pubmed: 32673298
Cell Immunol. 2017 Nov;321:3-7
pubmed: 28923237
Cell. 2020 Dec 23;183(7):1946-1961.e15
pubmed: 33306960
Nat Rev Immunol. 2020 Sep;20(9):529-536
pubmed: 32728222
Curr Opin Immunol. 2010 Jun;22(3):397-401
pubmed: 20427170
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
J Clin Virol. 2013 Dec;58(4):689-95
pubmed: 24140015
Cell. 2020 Nov 12;183(4):968-981.e7
pubmed: 32966765
Clin Exp Immunol. 2006 Feb;143(2):345-56
pubmed: 16412060
JAMA. 2020 Jul 21;324(3):246-248
pubmed: 32511667
Clin Infect Dis. 2020 Jul 28;71(15):833-840
pubmed: 32296824
Curr Opin Immunol. 2012 Aug;24(4):476-81
pubmed: 22554789
Am Rev Respir Dis. 1979 Sep;120(3):700-4
pubmed: 314763
Nat Med. 2020 Dec;26(12):1951
pubmed: 33247289
J Leukoc Biol. 2000 Apr;67(4):577-84
pubmed: 10770292
Nature. 2006 Sep 21;443(7109):350-4
pubmed: 16921384
J Pediatric Infect Dis Soc. 2020 Dec 02;:
pubmed: 33263756
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
Immunity. 2007 Oct;27(4):670-84
pubmed: 17950003
Nat Med. 2020 Dec;26(12):1819-1824
pubmed: 33139949
Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10133-8
pubmed: 27543331
Vaccine. 2009 Sep 18;27(41):5543-9
pubmed: 19647065
Pediatr Blood Cancer. 2020 Nov;67(11):e28693
pubmed: 32885904
Cancer Res. 2018 Sep 1;78(17):5175
pubmed: 30115702
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Sci Immunol. 2018 Jun 1;3(24):
pubmed: 29858286
Immunity. 2019 May 21;50(5):1172-1187.e7
pubmed: 31076359
J Immunol. 2016 Aug 15;197(4):1017-22
pubmed: 27430722
Nat Commun. 2016 Jun 23;7:11653
pubmed: 27337592
Cell Rep. 2018 Apr 17;23(3):768-782
pubmed: 29669283
Immunity. 2015 Sep 15;43(3):591-604
pubmed: 26362266
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):285-286
pubmed: 32441751
Sci Transl Med. 2020 Oct 7;12(564):
pubmed: 32958614
Pediatrics. 2020 Jul;146(1):
pubmed: 32546583
N Engl J Med. 2009 Dec 24;361(26):2507-17
pubmed: 20007555
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):393-398
pubmed: 32463092
Cell. 1997 Nov 14;91(4):521-30
pubmed: 9390561
Sci Immunol. 2020 Jul 15;5(49):
pubmed: 32669287
J Leukoc Biol. 2018 Oct;104(4):691-699
pubmed: 29947427
N Engl J Med. 2020 Jul 23;383(4):347-358
pubmed: 32598830
Nat Med. 2020 Nov;26(11):1701-1707
pubmed: 32812012
J Clin Invest. 2017 Apr 3;127(4):1392-1404
pubmed: 28240602
Cell. 2020 Nov 12;183(4):982-995.e14
pubmed: 32991843
J Immunol. 2014 Oct 1;193(7):3528-37
pubmed: 25172499
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1074-1080
pubmed: 32790663
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1324-1329
pubmed: 32941417
Immunity. 2008 May;28(5):710-22
pubmed: 18468462
J Pediatr. 2021 Mar;230:23-31.e10
pubmed: 33197493

Auteurs

Laura A Vella (LA)

Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. vellal@chop.edu wherry@pennmedicine.upenn.edu.
Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Josephine R Giles (JR)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Parker Institute for Cancer Immunotherapy at University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Amy E Baxter (AE)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Derek A Oldridge (DA)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.

Caroline Diorio (C)

Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Leticia Kuri-Cervantes (L)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Cécile Alanio (C)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Parker Institute for Cancer Immunotherapy at University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

M Betina Pampena (MB)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Jennifer E Wu (JE)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Parker Institute for Cancer Immunotherapy at University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Zeyu Chen (Z)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Yinghui Jane Huang (YJ)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Elizabeth M Anderson (EM)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Sigrid Gouma (S)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Kevin O McNerney (KO)

Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Julie Chase (J)

Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Division of Rheumatology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Chakkapong Burudpakdee (C)

Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Jessica H Lee (JH)

Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Sokratis A Apostolidis (SA)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Division of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.

Alexander C Huang (AC)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.

Divij Mathew (D)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Oliva Kuthuru (O)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Eileen C Goodwin (EC)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Madison E Weirick (ME)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Marcus J Bolton (MJ)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Claudia P Arevalo (CP)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Andre Ramos (A)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

C J Jasen (CJ)

Division of Allergy and Immunology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA,19104, USA.

Peyton E Conrey (PE)

Division of Allergy and Immunology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA,19104, USA.

Samir Sayed (S)

Division of Allergy and Immunology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA,19104, USA.

Heather M Giannini (HM)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.

Kurt D'Andrea (K)

Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.

Nuala J Meyer (NJ)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.

Edward M Behrens (EM)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Division of Rheumatology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Hamid Bassiri (H)

Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Scott E Hensley (SE)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Sarah E Henrickson (SE)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Division of Allergy and Immunology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA,19104, USA.

David T Teachey (DT)

Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Michael R Betts (MR)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

E John Wherry (EJ)

Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. vellal@chop.edu wherry@pennmedicine.upenn.edu.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Parker Institute for Cancer Immunotherapy at University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH